公开(公告)号：US20230372336A1

公开(公告)日：2023-11-23

申请号：US18320173

申请日：2023-05-18

Applicant: INTRA-CELLULAR THERAPIES, INC.

Inventor： Sophie DUTHEIL ,  Gretchen SNYDER ,  Peng LI ,  Robert E. DAVIS

IPC: A61K31/4985 ,  A61P25/00 ,  A61P25/18

CPC classification number: A61K31/4985 ,  A61P25/00 ,  A61P25/18

Abstract: The disclosure provides methods the treatment of psychiatric disorders caused by viral, bacterial, or autoimmune encephalitis, and for treatment of psychiatric symptoms of viral, bacterial, and autoimmune encephalitis, and for protecting or reinforcing the blood-brain barrier, comprising administering to a patient in need thereof, a therapeutically effective amount of a 5-HT2A.

公开(公告)号：US20240122924A1

公开(公告)日：2024-04-18

申请号：US18518436

申请日：2023-11-22

Applicant: INTRA-CELLULAR THERAPIES, INC.

Inventor： Sophie DUTHEIL ,  Gretchen SNYDER ,  Peng LI ,  Robert E. DAVIS

IPC: A61K31/4985 ,  A61P25/18 ,  A61P25/22 ,  A61P25/24 ,  A61P29/00

CPC classification number: A61K31/4985 ,  A61P25/18 ,  A61P25/22 ,  A61P25/24 ,  A61P29/00

Abstract: The disclosure provides methods the treatment of psychiatric disorders caused by viral, bacterial, or autoimmune encephalitis, and for treatment of psychiatric symptoms of viral, bacterial, and autoimmune encephalitis, and for protecting or reinforcing the blood-brain barrier, comprising administering to a patient in need thereof, a therapeutically effective amount of a 5-HT2A.